Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability

New generation antidepressant therapies, including serotonin-norepinephrine reuptake inhibitor (SNRIs), were introduced in the late 1980s; however, few comprehensive studies have compared the benefits and risks of various contemporary treatments for major depressive disorder (MDD) in young patients....

Full description

Bibliographic Details

Published in:	Brazilian Journal of Medical and Biological Research
Main Authors:	Y. Xu, S.J. Bai, X.H. Lan, B. Qin, T. Huang, P. Xie
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2016-01-01
Subjects:	Adolescent Child Major depressive disorder Meta-analysis Randomized controlled trial Serotonin and norepinephrine reuptake inhibitor
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600704&lng=en&tlng=en